Cagrilintide is a long-acting amylin analogue peptide that primarily provides benefits in weight management, appetite suppression, and blood sugar regulation.]
Weight Loss and Appetite Control
Reduced hunger: It targets specific receptors in the brain to decrease food cravings and lower overall caloric intake.
Enhanced fullness: It slows down how fast food leaves your stomach (gastric emptying), helping you feel full for a longer time after eating.
Significant body weight reduction: Clinical studies show meaningful weight loss when used alone or amplified when combined with GLP-1 receptor agonists like semaglutide (known as CagriSema).
Metabolic and Blood Sugar Health
Postprandial glucose control: It helps keep blood sugar levels stable after meals by inhibiting glucagon secretion.
Cardiometabolic improvements: Trial data suggest secondary benefits for overall metabolic health, including improvements in blood pressure and glycemic markers for individuals struggling with obesity or type 2 diabetes.

